首页> 外文期刊>Indian Journal of Veterinary Surgery >Studies on diagnostic and therapeutic options in dogs suffering from benign prostatic hyperplasia
【24h】

Studies on diagnostic and therapeutic options in dogs suffering from benign prostatic hyperplasia

机译:良性前列腺增生症犬的诊断和治疗选择的研究

获取原文
获取原文并翻译 | 示例
           

摘要

The study was conducted on 10 dogs presented with prostate involvement with an aim to determine effective diagnostic and therapeutic options for managing benign prostatic hyperplasia (BPH). The disease was more common in middle to old aged dogs. Urinalysis revealed normal or concurrent urinary tract infection. Elevated activity of serum alkaline phosphatase was seen. Culture of prostatic fluid revealed no bacterial growth. Objective radiographic and ultrasonographic assessment was found superior to conventional subjective assessment. Ultrasound-guided fine-needle aspiration biopsy using free hand technique obtained good quality prostatic tissue sample for confirmatory diagnosis. The BPH cases were grouped under 3 groups that received either Finasteride (@ 5mg total dose for 6 weeks), Dutasteride (@ 0.5 mg total dose for 6 weeks) or underwent castration. Treatment with finasteride, dutasteride or castration produced similar and comparable results in the form of prostatic volume reduction and alleviation of clinical signs. Both drugs did not produce any deleterious effect on vital organ functions and were found safe in dogs.
机译:这项研究是对10只患前列腺的狗进行的,目的是确定治疗良性前列腺增生(BPH)的有效诊断和治疗选择。该病多见于中老年狗。尿液分析显示正常或并发尿路感染。观察到血清碱性磷酸酶活性升高。前列腺液的培养没有细菌生长。发现客观的射线照相和超声检查评估优于传统的主观评估。使用徒手技术的超声引导下细针穿刺活检获得了高质量的前列腺组织样本,用于确诊。将BPH病例分为3组,分别接受非那雄胺(@ 5mg总剂量,持续6周),度他雄胺(@ 0.5mg总剂量,持续6周)或接受去势。非那雄胺,度他雄胺或去势治疗以前列腺体积减少和临床体征减轻的形式产生了相似且可比的结果。两种药物均未对重要器官功能产生任何有害作用,并且在狗中被发现是安全的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号